FISHIntraductalPapillomaCachexiaMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMastectomyACChemotherapyMRILapatinibLCISNodePositiveGuaranteedRenewableInsuranceMorpheaBilateralProphylacticMastectomyGailModelEGFR(epidermalgrowth factorreceptor)PagetDiseaseWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.SERMNodeNegativeExcisionalBiopsyDocetaxelCytotoxicFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.HerceptinAntiemeticLymphoscintigraphyAromataseInhibitorsGeneticCounselingEstrogenTripleNegativeBreastCancerDimplingCapecitabineTriplePositiveBreastCancerGeneMutationCDK4/6InhibitorsCalcificationsTyrosine-KinaseInhibitorAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerAdvocacyTumorGradePalbociclibCheckpointInhibitorBevacizumabER+RelapsePARPInhibitorsKi-67RateMastodyniaFibroadenomaProgestinLumpectomyMegestrolAcetateInvasiveBreastCancerGenomicTestingPhyllodesTumorBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55BreastTomosynthesisPalpationPathologicResponseAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearTamoxifenAbsoluteRisk5-FluorouracilmTORInhibitorsCMFChemotherapyDoxorubicinKappaEpsilonAdenocarcinomaDefinitiveSurgeryAngiogenesisPI3KinaseInhibitorsApoptosisSelf-examination1 in 8womenBRCAGeneDoseDenseTherapyIn-situCarcinomaHER-2AntibodyTherapyAdjuvantTherapyAlopeciaNeoadjuvantTherapyOvarianSuppressionCystImmunotherapyBrachytherapyOligometastasesECOGScorePaclitaxelChemotherapyAyurvedaEstradiolFamilyHistoryCo-survivorNeoplasmPrecisionMedicinePhysicalactivity mayreduce therisk of breastcancersRADCyclophosphamideMethotrexateWomen ages40+ shouldhave a clinicalbreast examat least yearlyBreastCancerCAMLymphNodeStatusAnastrozoleBOCAHormoneReceptorStatusBI-RADSMultifocalTumorsAxillarySamplingGeneticPredispositionChemopreventionGermlineMutationBiopsyRadiotherapyDown-StagingCytostaticHormoneReplacementTherapyRaloxifeneER-MultimodalityTherapyLumpStagingMetastasisFlowCytometryFISHIntraductalPapillomaCachexiaMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltMastectomyACChemotherapyMRILapatinibLCISNodePositiveGuaranteedRenewableInsuranceMorpheaBilateralProphylacticMastectomyGailModelEGFR(epidermalgrowth factorreceptor)PagetDiseaseWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.SERMNodeNegativeExcisionalBiopsyDocetaxelCytotoxicFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.HerceptinAntiemeticLymphoscintigraphyAromataseInhibitorsGeneticCounselingEstrogenTripleNegativeBreastCancerDimplingCapecitabineTriplePositiveBreastCancerGeneMutationCDK4/6InhibitorsCalcificationsTyrosine-KinaseInhibitorAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerAdvocacyTumorGradePalbociclibCheckpointInhibitorBevacizumabER+RelapsePARPInhibitorsKi-67RateMastodyniaFibroadenomaProgestinLumpectomyMegestrolAcetateInvasiveBreastCancerGenomicTestingPhyllodesTumorBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55BreastTomosynthesisPalpationPathologicResponseAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearTamoxifenAbsoluteRisk5-FluorouracilmTORInhibitorsCMFChemotherapyDoxorubicinKappaEpsilonAdenocarcinomaDefinitiveSurgeryAngiogenesisPI3KinaseInhibitorsApoptosisSelf-examination1 in 8womenBRCAGeneDoseDenseTherapyIn-situCarcinomaHER-2AntibodyTherapyAdjuvantTherapyAlopeciaNeoadjuvantTherapyOvarianSuppressionCystImmunotherapyBrachytherapyOligometastasesECOGScorePaclitaxelChemotherapyAyurvedaEstradiolFamilyHistoryCo-survivorNeoplasmPrecisionMedicinePhysicalactivity mayreduce therisk of breastcancersRADCyclophosphamideMethotrexateWomen ages40+ shouldhave a clinicalbreast examat least yearlyBreastCancerCAMLymphNodeStatusAnastrozoleBOCAHormoneReceptorStatusBI-RADSMultifocalTumorsAxillarySamplingGeneticPredispositionChemopreventionGermlineMutationBiopsyRadiotherapyDown-StagingCytostaticHormoneReplacementTherapyRaloxifeneER-MultimodalityTherapyLumpStagingMetastasisFlowCytometry

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. FISH
  2. Intraductal Papilloma
  3. Cachexia
  4. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  5. Mastectomy
  6. AC Chemotherapy
  7. MRI
  8. Lapatinib
  9. LCIS
  10. Node Positive
  11. Guaranteed Renewable Insurance
  12. Morphea
  13. Bilateral Prophylactic Mastectomy
  14. Gail Model
  15. EGFR (epidermal growth factor receptor)
  16. Paget Disease
  17. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  18. SERM
  19. Node Negative
  20. Excisional Biopsy
  21. Docetaxel
  22. Cytotoxic
  23. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  24. Herceptin
  25. Antiemetic
  26. Lymphoscintigraphy
  27. Aromatase Inhibitors
  28. Genetic Counseling
  29. Estrogen
  30. Triple Negative Breast Cancer
  31. Dimpling
  32. Capecitabine
  33. Triple Positive Breast Cancer
  34. Gene Mutation
  35. CDK4/6 Inhibitors
  36. Calcifications
  37. Tyrosine-Kinase Inhibitor
  38. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  39. Advocacy
  40. Tumor Grade
  41. Palbociclib
  42. Checkpoint Inhibitor
  43. Bevacizumab
  44. ER+
  45. Relapse
  46. PARP Inhibitors
  47. Ki-67 Rate
  48. Mastodynia
  49. Fibroadenoma
  50. Progestin
  51. Lumpectomy
  52. Megestrol Acetate
  53. Invasive Breast Cancer
  54. Genomic Testing
  55. Phyllodes Tumor
  56. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  57. Breast Tomosynthesis
  58. Palpation
  59. Pathologic Response
  60. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  61. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  62. Tamoxifen
  63. Absolute Risk
  64. 5-Fluorouracil
  65. mTOR Inhibitors
  66. CMF Chemotherapy
  67. Doxorubicin
  68. Kappa Epsilon
  69. Adenocarcinoma
  70. Definitive Surgery
  71. Angiogenesis
  72. PI3 Kinase Inhibitors
  73. Apoptosis
  74. Self-examination
  75. 1 in 8 women
  76. BRCA Gene
  77. Dose Dense Therapy
  78. In-situ Carcinoma
  79. HER-2
  80. Antibody Therapy
  81. Adjuvant Therapy
  82. Alopecia
  83. Neoadjuvant Therapy
  84. Ovarian Suppression
  85. Cyst
  86. Immunotherapy
  87. Brachytherapy
  88. Oligometastases
  89. ECOG Score
  90. Paclitaxel
  91. Chemotherapy
  92. Ayurveda
  93. Estradiol
  94. Family History
  95. Co-survivor
  96. Neoplasm
  97. Precision Medicine
  98. Physical activity may reduce the risk of breast cancers
  99. RAD
  100. Cyclophosphamide
  101. Methotrexate
  102. Women ages 40+ should have a clinical breast exam at least yearly
  103. Breast Cancer
  104. CAM
  105. Lymph Node Status
  106. Anastrozole
  107. BOCA
  108. Hormone Receptor Status
  109. BI-RADS
  110. Multifocal Tumors
  111. Axillary Sampling
  112. Genetic Predisposition
  113. Chemoprevention
  114. Germline Mutation
  115. Biopsy
  116. Radiotherapy
  117. Down-Staging
  118. Cytostatic
  119. Hormone Replacement Therapy
  120. Raloxifene
  121. ER-
  122. Multimodality Therapy
  123. Lump
  124. Staging
  125. Metastasis
  126. Flow Cytometry